Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity
JAMA
About The Study: In participants with obesity or overweight, withdrawing tirzepatide led to substantial regain of lost weight, whereas continued treatment maintained and augmented initial weight reduction in this randomized clinical trial that included 670 adults.
Authors: Louis J. Aronne, M.D., of Weill Cornell Medicine in New York, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2023.24945)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo timehttps://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.24945?guestAccessKey=753fc442-37ad-47c9-9aac-307204ec3055&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121123
END
Authors: Louis J. Aronne, M.D., of Weill Cornell Medicine in New York, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2023.24945)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo timehttps://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.24945?guestAccessKey=753fc442-37ad-47c9-9aac-307204ec3055&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121123
END